Levetiracetam Kent Pharma Uk (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which regulates neurotransmitter release. By modulating this protein, the drug stabilises neuronal firing and diminishes the hyper‑excitability that leads to seizure activity, providing an anticonvulsant effect.

The appropriate dose of Levetiracetam is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed regimen is provided here; the prescriber sets the dosage.

Safety data for Levetiracetam during pregnancy and lactation are limited. Clinicians should weigh potential benefits against unknown risks and discuss options with the patient. Breastfeeding decisions should also be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levetiracetam offers a distinct mechanism (SV2A binding) compared with many traditional antiepileptics that target sodium channels or GABA receptors. It generally has fewer drug‑enzyme interactions, a relatively favourable side‑effect profile, and can be used as add‑on therapy, though individual response varies.

Store Levetiracetam at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Levetiracetam is taken orally, usually as tablets or oral solution, with or without food. The exact administration schedule (once, twice or multiple daily doses) is determined by the prescribing clinician based on therapeutic needs.

Serious risks include severe allergic reactions (anaphylaxis), life‑threatening skin conditions such as Stevens‑Johnson syndrome, blood dyscrasias, and the emergence of depressive symptoms or suicidal thoughts. Patients should seek immediate medical attention if any of these occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications that markedly reduce its efficacy.